+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Carboxes 602303-26-4
602303-26-4,MFCD08448166
Catalog No.:AA0037DK

602303-26-4 | 7-Chloro-2-iodothieno[3,2-b]pyridine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$22.00   $15.00
- +
250mg
95%
in stock  
$30.00   $21.00
- +
500mg
95%
in stock  
$54.00   $38.00
- +
1g
95%
in stock  
$68.00   $48.00
- +
5g
95%
in stock  
$226.00   $158.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0037DK
Chemical Name:
7-Chloro-2-iodothieno[3,2-b]pyridine
CAS Number:
602303-26-4
Molecular Formula:
C7H3ClINS
Molecular Weight:
295.5279
MDL Number:
MFCD08448166
SMILES:
Ic1cc2c(s1)c(Cl)ccn2
Properties
Properties
 
BP:
341.7±37.0°C at 760 mmHg  
Form:
Solid  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
157  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
XLogP3:
3.3  

Downstream Synthesis Route

[1]Ragan;Raggon;Hill;Jones;McDermott;Munchhof;Marx;Casavant;Cooper;Doty;Lu[OrganicProcessResearchandDevelopment,2003,vol.7,#5,p.676-683]

[2]CurrentPatentAssignee:SCORPIONTHERAPEUTICS-WO2022/72634,2022,A1Locationinpatent:Page/Pagecolumn326

[3]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN107151240,2017,ALocationinpatent:Paragraph0265;0266;0267

[4]Munchhof,MichaelJ.;Beebe,JeanS.;Casavant,JefferyM.;Cooper,BethA.;Doty,JonathanL.;Higdon,R.Carla;Hillerman,StephenM.;Soderstrom,CatherineI.;Knauth,ElisabethA.;Marx,MatthewA.;Rossi,AnnMarieK.;Sobolov,SusanB.;Sun,Jianmin[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.21-24]

[5]CurrentPatentAssignee:PFIZERINC-US2007/197537,2007,A1Locationinpatent:Page/Pagecolumn52

[6]Claridge,Stephen;Raeppel,Franck;Granger,Marie-Claude;Bernstein,Naomy;Saavedra,Oscar;Zhan,Lijie;Llewellyn,David;Wahhab,Amal;Deziel,Robert;Rahil,Jubrail;Beaulieu,Normand;Nguyen,Hannah;Dupont,Isabelle;Barsalou,Annie;Beaulieu,Carole;Chute,Ian;Gravel,Serge;Robert,Marie-France;Lefebvre,Sylvain;Dubay,Marja;Pascal,Roussen;Gillespie,Jeff;Jin,Zhiyun;Wang,James;Besterman,JeffreyM.;MacLeod,A.Robert;Vaisburg,Arkadii[BioorganicandMedicinalChemistryLetters,2008,vol.18,#9,p.2793-2798]

[7]Scott,RobertW.;Neville,ScanN.;Urbina,Armando;Camp,David;Stankovic,Nebojsa[OrganicProcessResearchandDevelopment,2006,vol.10,#2,p.296-303]

[8]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1Locationinpatent:Paragraph00641

[9]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1Locationinpatent:Page/Pagecolumn75;76

[10]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2Locationinpatent:Page/Pagecolumn361;362

[11]CurrentPatentAssignee:EFFECTORTHERAPEUTICSINC;EFFECTORTHERAPEUTICSINC;EFFECTTHERAPYSTOCKLTDCOMPANY-WO2021/3157,2021,A1Locationinpatent:Paragraph0311-0312;0342

[12]CurrentPatentAssignee:SICHUANKELUNPHARMACEUTICALCOMPANYLIMITED-EP3929185,2021,A1

[1]Munchhof,MichaelJ.;Beebe,JeanS.;Casavant,JefferyM.;Cooper,BethA.;Doty,JonathanL.;Higdon,R.Carla;Hillerman,StephenM.;Soderstrom,CatherineI.;Knauth,ElisabethA.;Marx,MatthewA.;Rossi,AnnMarieK.;Sobolov,SusanB.;Sun,Jianmin[BioorganicandMedicinalChemistryLetters,2004,vol.14,#1,p.21-24]

[2]Ragan;Raggon;Hill;Jones;McDermott;Munchhof;Marx;Casavant;Cooper;Doty;Lu[OrganicProcessResearchandDevelopment,2003,vol.7,#5,p.676-683]

[3]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2014/151147,2014,A1

[4]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/30588,2015,A1

[5]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US9295673,2016,B2

[6]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN107151240,2017,A

[1]CurrentPatentAssignee:PFIZERINC;CORTICAL-WO2003/106462,2003,A1Locationinpatent:Page74

[1]CurrentPatentAssignee:PFIZERINC;CORTICAL-WO2003/106462,2003,A1Locationinpatent:Page47;48

[2]CurrentPatentAssignee:CORTICAL;PFIZERINC-US2004/9965,2004,A1

[1]CurrentPatentAssignee:PFIZERINC;CORTICAL-WO2003/106462,2003,A1Locationinpatent:Page75

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 602303-26-4
94191-17-0

94191-17-0
Building Blocks
More >
Tags:602303-26-4 Molecular Formula|602303-26-4 MDL|602303-26-4 SMILES|602303-26-4 7-Chloro-2-iodothieno[3,2-b]pyridine